Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4903577

Cc1ccc(N)cc1-c1nccc(-c2ccncc2)n1.N

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 4/20 0.45
BCR P11274 3/20 0.45
SRC P12931 1/20 0.45
NPC1 O15118 2/20 0.44
GABRA1 P14867 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
IMPDH2 P12268 2/20 0.37
PIM1 P11309 1/20 0.36
PIM3 Q86V86 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
PLA2G7 Q13093 1/20 0.36
PIK3CB P42338 1/20 0.35
FYN P06241 1/20 0.35
JAK2 O60674 1/20 0.35
ASIC3 Q9UHC3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL2693849 0.84 ABL1 (0.62) ABL1BCRSRCMEN1HSP90AA1
SCHEMBL7476653 0.84 ABL1 (0.48) ABL1BCRSRCNPC1GABRA1
Hydrochloric Acid SCHEMBL5531500 0.83 ABL1 (0.61) ABL1BCRSRCMEN1HSP90AA1
SCHEMBL22206280 0.82 ABL1 (0.63) ABL1BCRSRCMEN1HSP90AA1
Ammonia Solution, Strong SCHEMBL4893301 0.79 NPC1 (0.44) NPC1MEN1KMT2APLA2G7HSP90AA1
Ammonia Solution, Strong SCHEMBL3088207 0.76 ABL1 (0.39) ABL1BCRMEN1KMT2APIM1
SCHEMBL25595422 0.75 AAK1 (0.48) JAK2CYP3A4
SCHEMBL25391936 0.74 PLA2G7 (0.50) NPC1PLA2G7HSP90AA1CYP3A4RAB9A
Pyridine SCHEMBL28228170 0.74 PLA2G7 (0.44) ABL1BCRNPC1PLA2G7HSP90AA1
SCHEMBL2580846 0.74 ABL1 (0.74) ABL1BCRSRCPRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US disclosed
EP-1786781-A2 PYRIMIDINE DERIVATIVES GPC Biotech AG (DE) 2007-05-23 EP disclosed
WO-2006021458-A2 PYRIMIDINE DERIVATIVES GPC BIOTECH AG (DE) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080187575-A1 Pyrimidine Derivatives TYMP, TDP1, PNP ABL1 2843/4885BCR 2315/4885SRC 3368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.